Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine besilate and nebivolol hydrochloride, the active ingredients in Nesyrgy, are a calcium channel blocker and a beta‑blocker presented as an oral tablet for oral use. They are indicated for the treatment of hypertension in adult patients. GNH USA supplies Nesyrgy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nesyrgy combines a calcium‑channel blocker and a beta‑blocker to manage hypertension.

Hypertension (essential): lowers both systolic and diastolic blood pressure. Isolated systolic hypertension: improves arterial compliance and reduces pulse pressure. High cardiovascular‑risk hypertension: adds heart‑rate control to reduce overall cardiovascular strain.

Common Side Effects: - Headache: mild to moderate intensity. - Peripheral edema: swelling of the ankles or feet. - Dizziness or light‑headedness, especially after standing. - Flushing: transient warmth and redness of the skin. - Fatigue or tiredness. - Palpitations: sensation of irregular heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Angioedema: swelling of face, lips, tongue, or throat. - Hepatic injury: abnormal liver function tests. - Bronchospasm: difficulty breathing, particularly in patients with asthma. - Cardiac conduction disorders: heart block or severe bradycardia. - Anaphylactic reactions: sudden severe allergic response.

Before initiating therapy, clinicians should assess cardiovascular status and monitor blood pressure regularly.

Monitor blood pressure: adjust dose if target not achieved. Assess cardiac function: especially in patients with heart failure. Caution in hepatic impairment: dose may need adjustment. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Use with caution in elderly patients: increased sensitivity to hypotensive effects. Store at ambient temperature: keep in original container, protect from moisture.

Nesyrgy may interact with several medicines that affect blood pressure or drug metabolism.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase amlodipine levels. - Concomitant use with other antihypertensives (e.g., ACE inhibitors, diuretics): additive hypotensive effect. - Phosphodiesterase‑5 inhibitors (e.g., sildenafil): risk of severe hypotension.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nebivolol concentrations. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can blunt antihypertensive response. - Other calcium‑channel blockers (e.g., verapamil, diltiazem): may increase amlodipine exposure. - Beta‑agonists (e.g., albuterol): may reduce nebivolol efficacy. - Diuretics: monitor electrolytes and renal function.